Evidence map›Paper›PMID 41522691›Full record

ArticleClinical kidney journal2026

Association of rheumatoid arthritis with chronic kidney disease.

Mathias Ausserwinkler, Andreas Kronbichler, Sophie Gensluckner, Simon Aberger, Bernhard Paulweber, Eugen Trinka, Patrick Langthaler, Bernhard Iglseder, Maria Flamm, Elmar Aigner and 1 more

Abstract read
In one paragraph

Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mathias AusserwinklerDepartment of Internal Medicine, Elisabethinen Hospital Klagenfurt, Austria.ORCID https://orcid.org/0009-0000-3353-8702
Andreas KronbichlerDepartment of Internal Medicine IV, Medical University, Innsbruck, Austria.ORCID https://orcid.org/0000-0002-2945-2946
Sophie GenslucknerFirst Department of Medicine, Landeskrankenhaus - Uniklinikum Paracelsus Medical University Salzburg, Austria.ORCID https://orcid.org/0009-0006-5008-7134
Simon AbergerFirst Department of Medicine, Landeskrankenhaus - Uniklinikum Paracelsus Medical University Salzburg, Austria.ORCID https://orcid.org/0000-0002-5721-2595
Bernhard PaulweberFirst Department of Medicine, Landeskrankenhaus - Uniklinikum Paracelsus Medical University Salzburg, Austria.ORCID https://orcid.org/0000-0002-1609-4676
Eugen TrinkaDepartment of Neurology, Neurointensive Care and Neurorehabilitation, Member of the European Reference Network EpiCARE, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Paracelsus Medical University Salzburg, Austria.ORCID https://orcid.org/0000-0002-5950-2692
Patrick LangthalerDepartment of Neurology, Neurointensive Care and Neurorehabilitation, Member of the European Reference Network EpiCARE, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Paracelsus Medical University Salzburg, Austria.ORCID https://orcid.org/0009-0007-7226-8371
Bernhard IglsederDepartment of Geriatric Medicine, Christian Doppler University Hospital, Paracelsus Medical University Salzburg, Salzburg, Austria.ORCID https://orcid.org/0000-0002-6132-8670
Maria FlammInstitute of General Practice, Family Medicine and Preventive Medicine, Center for Public Health and Healthcare Research, Paracelsus Medical University Salzburg, Salzburg, Austria.ORCID https://orcid.org/0000-0003-0816-6657
Elmar AignerFirst Department of Medicine, Landeskrankenhaus - Uniklinikum Paracelsus Medical University Salzburg, Austria.ORCID https://orcid.org/0000-0003-0310-0536
Bernhard WernlyFirst Department of Medicine, Landeskrankenhaus - Uniklinikum Paracelsus Medical University Salzburg, Austria.ORCID https://orcid.org/0000-0003-4024-0220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rheumatoid arthritis (RA) has been linked to an increased risk of chronic kidney disease (CKD), but the predominant renal phenotype and its independence from established risk factors remain unclear. We examined the RA-CKD association in a large, population-based cohort. Methods: RA and CKD were defined using American College of Rheumatology/European Alliance of Associations for Rheumatology and KDIGO criteria. Logistic regression models were employed with stepwise adjustment: first for cardiovascular risk [Systematic COronary Risk Evaluation 2 (SCORE2)], followed by a model including age, sex, metabolic syndrome, smoking status, non-steroidal anti-inflammatory drug (NSAID) use and high-sensitivity C-reactive protein. Interaction terms were tested to evaluate effect modification. Results: Among 9665 participants from the Paracelsus 10,000 cohort, 296 (3.1%) had RA. CKD prevalence was higher in the RA group compared with controls (11.8% vs 6.7%, Conclusions: RA is associated with a higher prevalence of CKD, primarily driven by albuminuria at preserved kidney function. This distinct renal phenotype appears largely mediated by metabolic comorbidities rather than inflammation alone. Our findings highlight the need for systematic albuminuria screening in RA patients to enable earlier detection and intervention.

Indexed as

chronic inflammationCKDCRPproteinuriaquality of life

Identifiers

PMID41522691
PMCPMC12783894

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.